- Education Level Now Prime Driver of COVID Vaccine Hesitancy: Poll
- Rheumatoid Arthritis Meds May Help Fight Severe COVID-19
- AHA News: From Mild COVID-19 to Heart Failure in 4 Weeks – at Age 20
- In Israel, Widespread Vaccination Slashes Severe COVID Cases in Older Patients
- Mental Health ‘Epidemic’ Threatens Communities of Color Amid COVID-19
- Expert Panel Set to Consider Approval of J&J COVID Vaccine
- Health Highlights: Feb. 26, 2021
- Pandemic Is Hitting Hospitals Hard, Including Their Bottom Line
- Common Antidepressants Won’t Raise Risk for Bleeding Strokes: Study
- Hair Salon Talk Can Spread COVID, But Face Shields Cut the Danger
Clinical Trials Update: July 1, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
High Cholesterol
This study seeks people aged 18 to 70 who take 40 mg. of Lipitor for high cholesterol. Qualified participants may be compensated up to $2,700.
The research site is in Phoenix, Ariz.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/high_cholesterol.aspx.
—–
Attention Deficit Hyperactivity Disorder (ADHD)
This study is for people with attention deficit hyperactivity disorder. You may qualify if you have trouble getting organized, paying attention or finishing tasks.
The research site is in Seattle, Wash.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/adhd.aspx.
—–
Iron-Deficiency Anemia
This study evaluating an intravenous iron medication seeks people with iron deficiency anemia and a history of unsatisfactory oral iron therapy.
The research site is in Atlanta, Ga.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/anemia.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
